We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+35.27%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$23.7M
Cap. Flow
-$10.9M
Cap. Flow %
-7.21%
Top 10 Hldgs %
49.48%
Holding
78
New
25
Increased
14
Reduced
22
Closed
12

Top Buys

Rank Stock Value
1
AVAV icon
AeroVironment
AVAV
+$3.78M
2
AXGN icon
Axogen
AXGN
+$2.78M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$2.41M
4
DRRX
DURECT Corp
DRRX
+$2.36M
5
CUTR
Cutera, Inc.
CUTR
+$1.95M

Top Sells

Rank Stock Value
1
BEAT
BioTelemetry, Inc.
BEAT
+$7.34M
2
MSTR icon
Strategy Inc
MSTR
+$4.07M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$3.69M
4
UI icon
Ubiquiti
UI
+$3.4M
5
COA
COASTAL CONTACTS INC COMMON SHARES (CANADA)
COA
+$2.89M

Sector Composition

Rank Sector Weight
1 Healthcare 50.2%
2 Technology 28.6%
3 Communication Services 5.65%
4 Industrials 3.63%
5 Materials 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTK
51
DELISTED
Rentech, Inc.
RTK
$351K 0.23%
17,706
-1,500
-8% -$31.5K
CDZI icon
52
Cadiz
CDZI
$334M
$226K 0.15%
+44,297
New +$213K
SB icon
53
Safe Bulkers
SB
$857M
$209K 0.14%
30,761
-14,200
-32% -$83.5K
ENT
54
DELISTED
Global Eagle Entertainment Inc.
ENT
$200K 0.13%
+852
New +$212K
SYT
55
DELISTED
Syngenta Ag
SYT
$187K 0.12%
+2,300
New +$185K
LFCR icon
56
Lifecore Biomedical
LFCR
$172M
$182K 0.12%
14,900
-1,100
-7% -$15.3K
CP icon
57
Canadian Pacific Kansas City
CP
$82.5B
$177K 0.12%
7,175
-2,250
-24% -$55.6K
GLOG
58
DELISTED
GASLOG LTD
GLOG
$143K 0.09%
9,600
+8,200
+586% +$114K
CAPL icon
59
CrossAmerica Partners
CAPL
$888M
$140K 0.09%
+5,000
New +$134K
OME
60
DELISTED
Omega Protein
OME
$120K 0.08%
+11,800
New +$110K
ECL icon
61
Ecolab
ECL
$80.1B
$109K 0.07%
1,100
– –
AGRO icon
62
Adecoagro
AGRO
$1.54B
$106K 0.07%
14,300
– –
VWTR
63
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$91K 0.06%
4,200
-12,700
-75% -$280K
OKS
64
DELISTED
Oneok Partners LP
OKS
$74K 0.05%
+1,400
New +$71K
EPD icon
65
Enterprise Products Partners
EPD
$84.3B
$73K 0.05%
+2,400
New +$73.4K
CERE
66
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$37K 0.02%
+3,125
New +$42.9K
ALT icon
67
Altimmune
ALT
$630M
– –
-2,683
Closed -$1.28M
FBIO icon
68
Fortress Biotech
FBIO
$93.4M
– –
-12,300
Closed -$1.59M
FMC icon
69
FMC
FMC
$1.33B
– –
-3,401
Closed -$180K
HDSN
70
Hudson Technologies
HDSN
$231M
– –
-127,974
Closed -$408K
LOGI icon
71
Logitech
LOGI
$14B
– –
-94,200
Closed -$663K
RIOT icon
72
Riot Platforms
RIOT
$7.84B
– –
-58,115
Closed -$558K
PRKR
73
DELISTED
Parkervision Inc
PRKR
– –
-10,220
Closed -$465K
IPXL
74
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-90,400
Closed -$1.8M
TEAR
75
DELISTED
TearLab Corporation
TEAR
– –
-1,280
Closed -$136K
1 2
3
4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Sophrosyne Capital held 78 positions worth $151M, up 19% from $128M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sophrosyne Capital withdrew a net $10.9M in Q3 2013, closing 12 positions and reducing 22 holdings. Its most notable exit was COASTAL CONTACTS INC COMMON SHARES (CANADA), an estimated $2.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Sophrosyne Capital opened a new position in AeroVironment worth $3.9M.

  • Sophrosyne Capital's largest Q3 2013 buy was AeroVironment: 169,426 shares worth $3.9M.
  • Sophrosyne Capital added most to Sarepta Therapeutics in Q3 2013, an estimated $2.41M increase.
  • Sophrosyne Capital's biggest Q3 2013 reduction was BioTelemetry, Inc., cutting an estimated $7.34M.
  • Sophrosyne Capital fully exited COASTAL CONTACTS INC COMMON SHARES (CANADA) in Q3 2013, selling an estimated $2.89M.
  • Sophrosyne Capital's ten largest holdings make up 49% of its $151M portfolio in Q3 2013.
  • Sophrosyne Capital opened 25 new positions and closed 12 in Q3 2013.
  • Sophrosyne Capital's portfolio value rose 19% quarter-over-quarter to $151M.

Based on Sophrosyne Capital's 13F filing for Q3 2013, filed 14 Nov 2013.